Therapeutic Solutions International Inc (TSOI)

[jackg22]

To give an example what "real" bio companies do, Capricor, as mentioned earlier, was wise enough to obtain millions in state funding as non- dilutive grants, then partnered with Japanese pharma for an upfront payment and milestone payments that will total close to a billion for one of their IP to treat muscular dystrophy. Capricor will be manufacturing it (think of us manufacturing the cells) and Japan pharma will be commercializing it in the US and Japan. This is how companies treat people and make money, the latter part which for some reason TSOI doesn't seem to understand how to accomplish.